ASX-listed Bod Australia signs deal to produce hemp-based mānuka honey

Sophie Boot
Thu, 18 Jan 2018

By Sophie Boot Jan. 18 (BusinessDesk) - ASX-listed Bod Australia has signed an agreement with mānuka honey producer Manuka Pharma to produce a hemp-based honey product line. Bod, a developer and distributor of cosmetics and natural medicines, is aiming to develop a range of over-the-counter and therapeutic products using cannabis extracts. It says it's building a sustainable, multi-faceted cannabis business through a deal with Swiss manufacturer Linnea Natural Pharma Solutions. The honey agreement will see Manuka Pharma source, develop an...

Unlock all stories
free for 10 days

Trustworthy, balanced journalism every day from our growing team of New Zealand business reporters and commentators, plus more in our weekend magazine section, The Life.

Instant News Alerts based on keywords you choose or journalists you follow
Our Daily Digest of all stories at 6am, midday or 6pm
Comprehensive business and markets coverage
News via email, web and Apple/Android apps

Try for 10 days without paying and if you’re not convinced cancel with just two clicks.

Find out more

Subscribe now

Name

E-Mail Address

Password

Confirm Password

We had trouble validating your card. It's possible your card provider is preventing us from charging the card. Please contact your card provider or customer support.

Cardholder's Name

Card

You will be charged in 10 days unless you cancel beforehand. We will remind you three times before charging you.
All subscriptions auto renew but are easy to cancel.

I Accept The Terms Of Service {{ registerForm.errors.get('terms') }}

Tax: {{ taxAmount(selectedPlan) | currency }}

Total Price Including Tax: {{ priceWithTax(selectedPlan) | currency }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerSeat ? '/ '+ spark.seatName : '' }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerTeam ? '/ '+ __('teams.team') : '' }} / {{ __(selectedPlan.interval) | capitalize }}

Or Subscribe with Google

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

Opinion FREE

Brian Gaynor: a 'titan' of NZ's capital markets

Jenny Ruth | Sat, 21 May 2022

Brian Roche remembers Brian Gaynor as "sorta scary and impressive at the same time – a real 'conscience' of what was right and fair."

On the Money

On the Money: Brian Gaynor tributes, Damien Grant's slip-up, Marsden Point and more

Pattrick Smellie | Sat, 21 May 2022

OTM this week: Tributes to a legend of the NZ investment world, who forgot to BCC their who's who subscriber list, a slightly bemusing no smoking note at the Budget lockup and more.

Law & Regulation

Unlawful collection of Companies Office fees fixed under urgency

Ian Llewellyn | Fri, 20 May 2022

The Companies Office's administration of fees may have saved costs, but the problem is it was against the law.

Partner content

What’s driving the ram raids, and what shop owners can do

Scott La Franchie explains the motivations behind the spate of burglaries.

Partner content

Grow your business by taking time to plan

Getting business fundamentals right gives the best chance at beating the unplannable.

ASX-listed Bod Australia signs deal to produce hemp-based mānuka honey

Subscribe now

Or Subscribe with Google

Not convinced yet?

Your company has a subscription

Team